PT  - JOURNAL ARTICLE
AU  - Li, Tianhong
AU  - Chen, Shuai
AU  - Ma, Weijie
AU  - Toomey, Kyra A
AU  - Long, Siqi
AU  - Lu, Tingting
AU  - Pineda, Colleen
AU  - Molnar, Laura
AU  - Garcia, Leslie
AU  - Tam, Kit
AU  - Verma, Rashmi
AU  - Zhou, Chihong
AU  - Ogilhara, Nancy
AU  - Babich, Michael
TI  - 632 A phase 1/2 open label study of LabVax 3(22)-23 and adjuvant GM-CSF alone or in combination with pembrolizumab in subjects with labyrinthin-positive adenocarcinomas
AID  - 10.1136/jitc-2023-SITC2023.0632
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A722--A722
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A722.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A722.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.